OP 150 Pill - green oval, 14mm
Generic Name: olaparib
Pill with imprint OP 150 is Green, Oval and has been identified as Lynparza 150 mg. It is supplied by AstraZeneca Pharmaceuticals LP.
Lynparza is used in the treatment of Ovarian Cancer; Breast Cancer, Metastatic; Prostate Cancer; Breast Cancer; Pancreatic Cancer and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OP 150
Lynparza
- Generic Name
- olaparib
- Imprint
- OP 150
- Strength
- 150 mg
- Color
- Green
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- PARP inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC)
- 00310-0679
- Inactive Ingredients
-
hypromelloses,
titanium dioxide,
copovidone,
silicon dioxide,
sodium stearyl fumarate,
ferric oxide yellow,
water,
polyethylene glycol 400,
mannitol,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "OP 150"
More about Lynparza (olaparib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (16)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
